Lung Cancer · 2016 · 73 citations · 22 references
MedicineOncologyPharmacotherapyCancer PharmacologyImmunotherapyNeoplasiaCancer ImmunotherapyMalignant NeoplasmsResponse AssessmentThymic Epithelial TumorsThymic Carcinoma Systemic TherapyThymic Neuroendocrine TumorsThymic PathologyThymic ToxicityThymic Tumors
22
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Anne-Marie O'Farrell, Tinya J. Abrams, Helene A. Yuen et al. · Blood · 2003 · 857 citations · Full text
Medicine, Oncology, Pharmacology +11